8QSX

Solution NMR structure of the novel adaptor domain TomBN91 from the Tomaymycin non-ribosomal peptide synthetase

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	300 uM [U-15N] TomBN91, 50 mM sodium phosphate, 150 mM sodium chloride, 1 mM TCEP, 0.02 % w/v sodium azide, 10 v/v [U-2H] D2O	90% H2O/10% D2O	265 mM	7.0	1 atm	298	Bruker AVANCE III HD 600
2	2D 1H-13C HSQC	500 uM [U-13C; U-15N] Non-ribosomal protein TomBN91, 50 mM sodium phosphate, 150 mM sodium chloride, 1 mM TCEP, 0.02 % w/v sodium azide, 10 % v/v [U-2H] D2O	90% H2O/10% D2O	265 mM	7.0	1 atm	298	Bruker AVANCE III HD 600
3	3D HNCO	500 uM [U-13C; U-15N] Non-ribosomal protein TomBN91, 50 mM sodium phosphate, 150 mM sodium chloride, 1 mM TCEP, 0.02 % w/v sodium azide, 10 % v/v [U-2H] D2O	90% H2O/10% D2O	265 mM	7.0	1 atm	298	Bruker AVANCE III HD 600
4	3D HNCA	500 uM [U-13C; U-15N] Non-ribosomal protein TomBN91, 50 mM sodium phosphate, 150 mM sodium chloride, 1 mM TCEP, 0.02 % w/v sodium azide, 10 % v/v [U-2H] D2O	90% H2O/10% D2O	265 mM	7.0	1 atm	298	Bruker AVANCE III HD 600
5	3D HNCACB	500 uM [U-13C; U-15N] Non-ribosomal protein TomBN91, 50 mM sodium phosphate, 150 mM sodium chloride, 1 mM TCEP, 0.02 % w/v sodium azide, 10 % v/v [U-2H] D2O	90% H2O/10% D2O	265 mM	7.0	1 atm	298	Bruker AVANCE III HD 600
6	3D HN(COCA)CB	500 uM [U-13C; U-15N] Non-ribosomal protein TomBN91, 50 mM sodium phosphate, 150 mM sodium chloride, 1 mM TCEP, 0.02 % w/v sodium azide, 10 % v/v [U-2H] D2O	90% H2O/10% D2O	265 mM	7.0	1 atm	298	Bruker AVANCE III HD 600
7	3D HN(CO)CA	500 uM [U-13C; U-15N] Non-ribosomal protein TomBN91, 50 mM sodium phosphate, 150 mM sodium chloride, 1 mM TCEP, 0.02 % w/v sodium azide, 10 % v/v [U-2H] D2O	90% H2O/10% D2O	265 mM	7.0	1 atm	298	Bruker AVANCE III HD 600
8	3D HCCH-TOCSY	500 uM [U-13C; U-15N] Non-ribosomal protein TomBN91, 50 mM sodium phosphate, 150 mM sodium chloride, 1 mM TCEP, 0.02 % w/v sodium azide, 10 % v/v [U-2H] D2O	90% H2O/10% D2O	265 mM	7.0	1 atm	298	Bruker AVANCE III HD 600
9	3D TOCSY-HSQC	500 uM [U-13C; U-15N] Non-ribosomal protein TomBN91, 50 mM sodium phosphate, 150 mM sodium chloride, 1 mM TCEP, 0.02 % w/v sodium azide, 10 % v/v [U-2H] D2O	90% H2O/10% D2O	265 mM	7.0	1 atm	298	Bruker AVANCE III HD 600
10	3D HBHA(CO)NH	500 uM [U-13C; U-15N] Non-ribosomal protein TomBN91, 50 mM sodium phosphate, 150 mM sodium chloride, 1 mM TCEP, 0.02 % w/v sodium azide, 10 % v/v [U-2H] D2O	90% H2O/10% D2O	265 mM	7.0	1 atm	298	Bruker AVANCE III HD 600
11	3D 1H-15N NOESY	300 uM [U-15N] TomBN91, 50 mM sodium phosphate, 150 mM sodium chloride, 1 mM TCEP, 0.02 % w/v sodium azide, 10 v/v [U-2H] D2O	90% H2O/10% D2O	265 mM	7.0	1 atm	298	Bruker AVANCE III HD 600
12	3D 1H-13C NOESY	800 uM [U-13C; U-15N] TomBN91, 50 mM sodium phosphate, 150 mM sodium chloride, 1 mM TCEP, 0.02 % w/v sodium azide, 10 % v/v [U-2H] D2O	90% H2O/10% D2O	265 mM	7.0	1 atm	298	Bruker AVANCE III HD 850

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III HD	600
2	Bruker	AVANCE III HD	850

NMR Refinement
Method	Details	Software
simulated annealing		CNS
torsion angle dynamics		CNS
molecular dynamics		CNS

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	10
Representative Model	3 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin		Bruker Biospin
2	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
7	peak picking	CcpNmr Analysis		CCPN
3	chemical shift assignment	CcpNmr Analysis	2.4	CCPN
4	data analysis	CcpNmr Analysis		CCPN
5	structure calculation	ARIA	2.3	Linge, O'Donoghue and Nilges
6	refinement	CNS	1.21	Brunger, Adams, Clore, Gros, Nilges and Read
8	refinement	CNS	1.21	Brunger, Adams, Clore, Gros, Nilges and Read
9	refinement	CNS	1.21	Brunger, Adams, Clore, Gros, Nilges and Read

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.